Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

drug-trials

How COVID-19 has affected the oncology drugs market

January 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …

Feature
lilly_building_with_american_flag_web

Lilly’s antibody could reduce COVID-19 risk by 80%, trial shows

January 22, 2021
Medical Communications COVID-19, Eli Lilly

Eli Lilly’s neutralising antibody bamlanivimab significantly reduced the risk of contracting symptomatic coronavirus among residents and staff of long-term care …

News

Thousands of Israelis test positive for COVID-19 after receiving Pfizer jab

January 21, 2021
COVID-19, Pfizer, israel

Thousands of people in Israel have tested positive for coronavirus after receiving the Pfizer vaccine, including some who had been …

News

Pfizer-BioNTech COVID-19 vaccine likely to protect against UK variant, study says

January 20, 2021
Research and Development COVID-19, Pfizer

The Pfizer-BioNTech COVID-19 vaccine is likely to protect against the coronavirus variant found in Britain, the latest research says. The …

News
covaxin

Bharat Biotech advises certain groups against taking its COVID-19 vaccine

January 19, 2021
Manufacturing and Production Bharat Biotech, COVID-19

India’s vaccine developer Bharat Biotech has advised a number of groups to avoid taking its homegrown COVID-19 vaccine, Covaxin. According …

News

ConserV and Lawrence Livermore National Laboratory to collaborate on coronavirus vaccine

January 19, 2021
Manufacturing and Production COVID-19, ConserV Bioscience

ConserV Bioscience, a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and Lawrence …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

January 15, 2021
Medical Communications COVID-19

Pharmafile.com’s most popular stories this week include the use of two new, potentially life-saving treatments for on COVID-19 patients, and …

News
alexion_sign2

Alexion pauses Phase III ULTOMIRIS COVID-19 trial enrolment

January 15, 2021
Medical Communications Alexion, COVID-19

Alexion has paused further enrolment in the global Phase III study of ULTOMIRIS (ravulizumab-cwvz) in adult COVID-19 patients requiring mechanical …

News
image_readtop_2018_569751_15365546683454581

Celltrion announces positive top-line results from COVID-19 treatment trial

January 14, 2021
COVID-19, celltrion

Celltrion Group has announced that top-line results from its global Phase II/III clinical trial of CT-P59, an anti-COVID-19 monoclonal antibody …

News

Trial of potential new COVID-19 treatment begins in UK

January 13, 2021
Research and Development COVID-19, Synairgen, Vaccine

A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …

News
moderna_norwood_plant

Switzerland approves Moderna’s COVID-19 vaccine

January 13, 2021
Research and Development COVID-19, Moderna, Vaccine

Moderna has announced that its COVID-19 vaccine has been authorised for use on those aged 18 or older in Switzerland. …

News
astrazeneca-sign

AstraZeneca seeks EU approval for COVID-19 vaccine

January 12, 2021
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …

News
vaccination

Seven mass vaccination sites open in England

January 11, 2021
Sales and Marketing COVID-19, UK, Vaccine

Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …

News

Pfizer’s COVID-19 vaccine protects against variants, research shows

January 8, 2021
Medical Communications COVID-19, Pfizer, Vaccine

Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …

News

Bayer and CureVac to collaborate on COVID-19 vaccine candidate

January 8, 2021
Medical Communications Bayer, COVID-19, Vaccine

Bayer is joining forces with CureVac, a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), on its COVID-19 …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026